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Abstract
Immunoglobulin (Ig) GM and KM allotypes, genetic markers of c and k chains, are associated with humoral immune
responsiveness. Previous studies have shown the relationships between GM6-carrying haplotypes and susceptibility to
malaria infection in children and adults; however, the role of the genetic markers in placental malaria (PM) infection and PM
with HIV co-infection during pregnancy has not been investigated. We examined the relationship between the gene
polymorphisms of Ig GM6 and KM allotypes and the risk of PM infection in pregnant women with known HIV status. DNA
samples from 728 pregnant women were genotyped for GM6 and KM alleles using polymerase chain reaction-restriction
fragment length polymorphism method. Individual GM6 and KM genotypes and the combined GM6 and KM genotypes
were assessed in relation to PM in HIV-1 negative and positive women, respectively. There was no significant effect of
individual GM6 and KM genotypes on the risk of PM infection in HIV-1 negative and positive women. However, the
combination of homozygosity for GM6(+) and KM3 was associated with decreased risk of PM (adjusted OR, 0.25; 95% CI,
0.08–0.8; P= 0.019) in HIV-1 negative women while in HIV-1 positive women the combination of GM6(+/2) with either KM1-
3 or KM1 was associated with increased risk of PM infection (adjusted OR, 2.10; 95% CI, 1.18–3.73; P= 0.011). Hardy-
Weinberg Equilibrium (HWE) tests further showed an overall significant positive F(is) (indication of deficit in heterozygotes)
for GM6 while there was no deviation for KM genotype frequency from HWE in the same population. These findings suggest
that the combination of homozygous GM6(+) and KM3 may protect against PM in HIV-1 negative women while the HIV-1
positive women with heterozygous GM6(+/2) combined with KM1-3 or KM1 may be more susceptible to PM infection. The
deficit in heterozygotes for GM6 further suggests that GM6 could be under selection likely by malaria infection.
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Introduction
Malaria is a major global public health problem and affects sub-
Saharan Africa predominantly [1]. Annually, about 125 million
pregnant women living in malaria-endemic areas, with 32 million
in sub-Saharan Africa, are at risk of malaria [2], and nearly 10,000
of these women and 200,000 infants die due to the direct or
indirect consequences of maternal Plasmodium falciparum infection
[2,3]. Inhabitants of malaria-endemic regions usually develop
protective immunity. However, because this protection is de-
creased during pregnancy, pregnant women are at higher risk of
malaria infection than their age-matched non-pregnant women
[4], with malaria parasites sequestering in the placenta due to the
selection of pregnancy-associated P. falciparum erythrocyte mem-
brane protein-1 (PfEMP-1) variant surface antigen (VSA) [5].
Placental malaria (PM) is often associated with maternal illness
and fetal loss in low transmission areas; in high transmission areas,
most mothers are asymptomatic but suffer from maternal anemia,
preterm labor, and low-birth weight infants contributing to
increased risk of neonatal and infant morbidity and mortality
[3,6,7]. Malaria and human immunodeficiency virus (HIV)
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infection often overlap in women of reproductive age in many sub-
Saharan African countries, emphasizing the public health impor-
tance of this co-infection. Co-infection with HIV in pregnant
women increases the risk of malaria infection, high parasite
density, maternal anemia, low-birth weight infants and congenital
malaria infection [8].
Although the immunological mechanisms responsible for
eliminating parasites from the placenta remain unclear, humoral
immune responses have been implicated. Unlike multigravidae,
primigravid women are more susceptible to PM and are less likely
to have the antibodies that inhibit the binding of infected red
blood cells to chondroitin sulfate A (CSA) in the placenta. The
previous studies on parity-dependent antibody responses further
suggest the existence of pregnancy-associated VSA expressed on
infected red blood cells [9,10,11]. In addition, naturally acquired
antibody responses to other blood stage antigens such as the C
terminus of merozoite surface protein 119 (MSP-119) have been
shown to be associated with reduced PM infection [11]. However,
HIV infection selectively alters humoral immune functions [12],
diminishes the development of parity-dependent antibody re-
sponses to pregnancy-associated VSA and impairs humoral
responses to other malaria antigens in pregnant women [13,14].
Furthermore, the effect of gene polymorphism in Fc receptors for
antibody IgG (FccRs) has been investigated in malaria during
pregnancy with or without HIV co-infection [15]. FccRs are
expressed on monocytes, macrophages, B-cells, and other leuko-
cytes and by binding to the antibody Fc-portion, they provide an
important link between the humoral and cellular arms of the
immune system for effector function and for immune modulation
[16]. Our previous report showed that the genotype of FccRIIa-
H/H131 was associated with enhanced susceptibility to PM in
HIV-positive women while the same FccRIIa genotype was found
to be less important for PM in HIV-negative women [15]. These
results indicate that the particular genotype of FccRIIa and
possible polymorphisms in the Fc portion of IgG may epistatically
interact, contributing to the disease-specific effector responses
mediated by IgG molecules [17].
Polymorphisms in the Fc portion of IgG called Ig GM and KM
allotypes are genetic markers of c and k chains, inherited as
autosomal codominant genes according to Mendelian laws [18].
GM allotypes are encoded by three very closely linked cistrons on
chromosome 14. They are localized on the constant region of c1,
c2 and c3 heavy chains, and there are currently 18 testable GM
specificities [19]. Linkage disequilibrium in the GM system is
almost absolute, and the determinants are transmitted as a group
called GM haplotypes. KM determinants are inherited via three
alleles on chromosome 2–KM1, KM1,2 and KM3. The clinical
importance of Ig GM and KM allotypes has been evaluated for a
number of other infectious diseases such as infections with hepatitis
C virus or Haemophilus influenzae type b bacteria. These studies
showed strong associations between specific Ig GM and KM
polymorphisms and susceptibility to and outcome of infections
[19,20]. However, their roles in PM infection and PM with HIV
co-infection have not been investigated. A previous study found an
inverse relationship between the carriage of the GM5,6,13,14
(expressed on IgG3);1,17(expressed on IgG1) phenotype and
uncomplicated malaria in children [21], and results from another
study indicated that the critical element in differences in
susceptibility to malaria infection seen between two sympatric
tribes in eastern Sudan might be GM6-carrying haplotypes [22].
In addition, the geographic distribution of GM6-related haplo-
types coincides with the region of high falciparum malaria, sickle-
cell allele and G6PD deficiency prevalence [23,24]. GM6 is also
confined in sub-Saharan Africa and rarely found in other
continents, with the exception of African-Americans in North
America [24].
Given the relevance of GM6 in malaria infection in non-
pregnant populations [21,22,23] and the possibility that Ig GM
and KM allotypes may contribute to the risk of PM infection and
PM with HIV co-infection by epistatic interaction with FccR
[15,17], the aim of this study was to investigate the association
between gene polymorphisms of Ig GM6, KM allotypes and PM
infection in Kenyan pregnant women with known HIV status. In
addition, we further evaluated possible selection by malaria on Ig
GM6 and KM in the study population.
Patients and Methods
Ethics Statement
This study was approved by the Ethical Review Committee of
the Kenya Medical Research Institute, Nairobi, Kenya and the
Institutional Review Board of the Centers for Disease Control and
Prevention, Atlanta, Georgia, USA. Informed written consent was
obtained from all study participants.
Study Participants and Data Collection
This study was integrated into an observational cohort study
(VT project) investigating the effect of PM on perinatal mother-to-
child transmission of HIV-1 in western Kenya. Details of the study
design, population and clinical procedures have been published
elsewhere [15,25]. Briefly, pregnant women attending the
antenatal clinic at New Nyanza Provincial General Hospital in
Kisumu from 1996–2001 were enrolled. Inhabitants of this area
are predominantly of the Luo ethnic tribe. At enrollment, a
questionnaire was administered to extract information on repro-
ductive history, socio-demographics, behavior, and clinical status.
Blood samples were taken from mothers for HIV-antibody testing,
as well as malaria blood smears and hemoglobin level. At delivery,
blood samples were collected from the periphery, placenta and
cord to determine placental parasitemia, hemoglobin level and
viral load. One month postpartum, additional blood samples were
obtained from the mothers for CD4 cell counts, hemoglobin and
malaria diagnosis. The maternal samples collected at delivery were
used for the current genetic study. The VT cohort study originally
enrolled 269 HIV-negative and 829 HIV-positive pregnant
women. The difference in the number of women in the two
groups was due to the fact that enrollment priority was given to
HIV-positive women. For the HIV-negative women, enrollment
priority was given to the women with PM. For the present genetic
study, only those women who had maternal DNA samples and
clinical data with no missing information on antimalarial drug
treatment during pregnancy were included. Four groups of
pregnant women in the current study are: (a) 132 HIV-1 negative
women with PM, (b) 107 HIV-1 negative women without PM, (c)
119 HIV-1 positive women with PM, and (d) 370 HIV-1 positive
women without PM.
Laboratory Procedures
Malaria and anemia diagnosis. PM was assessed on blood
samples obtained from a shallow incision on the maternal side of
the placenta. Thick smears were made from the maternal and
placental blood and examined by microscopy. Parasite densities
were calculated based on 8,000 leukocytes/mL blood having
counted 300 leukocytes. Placental smear readings were also
categorized on the basis of malarial pigment in placental
intervillous macrophages [26]. Peripheral blood hemoglobin
concentrations were measured using HemoCue system (Hemo-
Cue).
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HIV-1 serological diagnosis, CD4 count and viral
load. Maternal HIV-status was determined by a primary
Serotrip HIV-1/2 (Saliva Diagnostic Systems) and a confirmatory
Capillus HIV-1/2 test (Cambridge Diagnostics). Maternal CD4
counts were determined by the use of commercial monoclonal
antibodies and standard fluorescent-activated cell sorting analysis
of whole blood (FACScan, Becton Dickinson). Maternal HIV-1
load was measured by use of the Roche Amplicor HIV-1 monitor
(test version 1.0; Roche Diagnostics).
GM6 and KM genotyping. Genomic DNA was purified
from frozen blood pellets by micro-centrifugation using a
commercial DNA purification mini-kit QIAmpH (Qiagen). Since
there are no published methods for molecular genotyping of GM6,
a polymerase chain reaction-restriction fragment length polymor-
phism (PCR-RFLP) method was developed for this investigation
based on the amino acid sequence information provided by Dard
et al. [27]. According to these authors, GM6 is determined by a
glutamine (CAG) to glutamic acid (GAG) substitution at position
419 (CH3 region) of IgG3. The position of the GM6 C/G SNP
has a unique cutting site for the restriction enzyme Fnu4HI. Two
sites were chosen, where the IgG3 gene differed from the genes for
other IgG subclasses, for use as forward and reverse primers.
Briefly, the DNA segment encoding the CH3 region of human c3
chain determinant GM6 gene was amplified by PCR using the
following primers: Forward primer: 5’-GCGGGCAGCCGGA-
GAACAACTACAAC-3’ and Reverse primer: 5’-
GCTTGCCGGCTATCGCACTC-3’. After digestion with
Fnu4HI and the fragments separated on 8% polyacrylamide gel,
the following products corresponding to the three genotypes were
detected: GM6[+] (206-bp fragment), GM6[+/2] (206-bp, 110-bp
and 96-bp fragment) and GM6[2] (110-bp and 96-bp fragment)
(Figure 1). For quality control of this RFLP method for GM6, we
randomly sequenced 133 samples; of these, 118 matched the PCR-
RFLP results. With the remaining 15 samples, the results were
inconclusive because the quality of sequencing was not acceptable.
To our knowledge, GM6 is found exclusively in the populations of
African descent. Therefore, in another measure of quality control
for the GM6 RFLP method, we genotyped 114 HIV-infected
Caucasian subjects for GM6; none was positive for this
determinant. k chain determinants KM1 and KM3 were
characterized by the PCR-RFLP technique published by Moxley
and Gibbs using the following primers: 5’-TAGGGGGAAGC-
TAGGAAGAAA-3’ and 5’-AAAAAGGGTCAGAGGCCAAA-3’
for PCR [28]. After digestion of the amplified product (538-bp)
with the restriction enzyme Acc1, the following products
corresponding to the three genotypes were detected: KM1 (538-
bp fragment), KM3 (390-bp and 148-bp fragment) and KM1-3
(538-bp, 390-bp and 148-bp fragment).
Definitions
Clinical definitions. Placental parasitemia was defined as P.
falciparum asexual form detected on a thick film. Peripheral
parasitemia was similarly defined as P. falciparum asexual form
detected on a thick film. After the inspection of 100 fields with no
parasite found, the thick film was deemed negative. Placentas with
malarial pigment in the absence of parasitemia were classified as
negative for PM. Gravidity was divided into primigravid,
secundigravid and multigravid (3 or more pregnancies). Newborn
low-birth weight (,2500 g) was classified based on weight
measured within 24 hours of birth. Preterm delivery was defined
as occurrence at ,37 weeks of gestation age assessed by the
Ballard method [29]. Malaria transmission season comprised the
months of April–June and October–December. The variable
‘‘malaria transmission season, third trimester’’ was defined as the
women who encountered malaria transmission season during the
last 3 months before delivery. The variable ‘‘anti-malarial use,
third trimester’’ was based on the self-reported treatment during
third trimester. Maternal anemia was defined as ,11 g/dL and
severe anemia as ,7 g/dL at third trimester. CD4 cell counts
were compared with cutoffs ,350 cells/ml and ,500 cells/ml.
Maternal HIV-1 positive status was determined on the basis of
antibodies to HIV-1, detected by two sequential rapid serological
tests. Maternal viral-load was quantified and assigned values
,1000 copies/ml, 1000–9999 copies/ml and $10,000 copies/
ml.
Genetic definitions. For GM6, individual genotypes are
GM6(+), GM6(2), and GM6(+/2), and for KM, they are KM1,
KM3, and KM1-3 [18]. As previous studies have reported that
GM and KM interactions, rather than GM or KM alone, play an
important role in control of immune responses [20,30,31,32],
combinations of GM6 and KM genotypes were further used to
explore the genetic association with PM in HIV-1 negative and
positive women, respectively. The models for combination of
genotypes in this study consist of the above three different
individual GM6 genotypes combined with either (a) KM1-3(+) or
(2), (b) KM1(+) or (2), or (c) KM3(+) or (2). Among these
combination models, KM1-3(+) is KM1-3 heterozygote and KM1-
3(2) includes KM1 and KM3 homozygotes. Using the model that
includes two homozygous KM1 and KM3 in a single KM
genotypic class (KM1-3(2)) enables us to examine the role of KM
heterozygosity combined with GM6 genotypes in PM.
Statistical Analysis
Because of the stratified enrollment in the main VT epidemi-
ological study, all analyses were conducted in HIV-1 negative and
HIV-1 positive women separately. Univariable analyses were
based on Pearson x2 tests for comparison of proportions and
Wilcoxon rank sum tests were used for comparison of continuous
distributions. Categorical and continuous variables included in the
initial univariable analysis for characteristics were mother’s age,
gravidity, maternal peripheral malaria, placental malaria pigment,
preterm delivery, newborn birth weight, maternal anemia, anti-
malarial use, malaria transmission season during third trimester,
maternal CD4 count and maternal HIV-1 load. The effects of
individual GM6 and KM genotypes, and combined genotypes on
PM were analyzed using a multivariable logistic regression model
controlling for gravidity, anti-malarial use, and malaria transmis-
sion season during the third trimester, all of which were significant
in univariable analyses. GM6(2) and KM3 were used as
references for the individual genotype analysis while GM6(2)
Figure 1. Restriction fragment length polymorphism analysis
for GM6 markers.
doi:10.1371/journal.pone.0053948.g001
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with either KM1-3(2), KM1(2) or KM3(2) were used as
references in the multivariable logistic regression analysis for the
combined genotypes. Odds ratios (OR) with 95% confidence
intervals (CI) were used to measure the strength of associations. All
tests were two-tailed and statistical significance was defined as
P,0.05. In addition, in order to evaluate the possible presence of
selection, Chi-square goodness of fit tests for the departures from
Hardy-Weinberg Equilibrium (HWE) in GM6 and KM genotypes
and allele frequencies and the inbreeding coefficients (F(is)) were
calculated based on the previously published formula [33,34]. The
HWE and F(is) were examined in whole study population and in
four groups stratified by disease status. Data analysis was
performed using SAS version 9.2 and the Hardy Weinberg
package in R version 2.12.
Results
Characteristics of Study Participants
The profile of participants’ characteristics is summarized in
Table 1 (n = 728). Since known and potential confounding
variables associated with PM may differ by HIV-1 status, all the
data analysis was conducted separately for HIV-1 negative and
positive women. Our data showed that younger mothers were
more likely to have PM than the older mothers (P,0.01),
irrespective of their HIV-1 status. In HIV-1 negative women,
univariable analysis showed that primigravid women were more
likely to have PM than multigravid women. However, the
gravidity-dependency of PM was not evident in HIV-1 positive
women. Malaria transmission season during third trimester was
found to be positively associated with PM. Irrespective of HIV-1
status, PM was statistically associated with maternal peripheral
malaria presence during the third trimester and at delivery,
malaria pigment present, and newborn birth weight ,2500 g
(Table 1). In HIV-1 positive women, PM was significantly
associated with maternal anemia at delivery (,7 g/dL and
,11 g/dL). Proportion of anti-malarial use during third trimester
in HIV-1 positive women was higher in the women without PM
than those with PM. Furthermore, HIV-1 positive women with
PM were significantly more likely to have maternal HIV-1 viral-
load copies/ml $10, 000 (Table 1).
Analysis of the Effect of Individual GM6 and KM
Genotypes on PM Infection with or without HIV-1
In univariable analysis, a borderline significant association
between GM6(+) and GM6(+/2) genotypes and PM in HIV
negative women was found, women without PM having higher
frequencies of these genotypes (Pa=0.05, Table 2), but a similar
association was not seen in HIV-1 positive women. There was no
difference in the distribution of KM genotypes between women
with PM and those without PM in both HIV-1 negative and HIV
positive groups (Table 2). In multivariable analysis using GM6(2)
and KM3 as references, the statistical significance earlier observed
with GM6 genotypes disappeared after controlling for confounders
(Table 3). Overall, there was no effect of the individual GM6 and
KM genotypes on the risk of PM in either HIV-1 negative or
positive women (Table 3).
Analysis of the Combined GM6 and KM Genotypes in
Relation to Risk of PM with and without HIV-1
Since none of the GM6 and KM genotypes were by themselves
significantly associated with PM in HIV-1 negative and positive
women after adjusting for confounders, and since previous studies
also showed an interactive effect of GM and KM in immune
response [20,30,31,32], we further analyzed 3 combinations of
GM6 and KM genotypes (Tables 4 and 5). In HIV-1 negative
women, there was no statistical association between PM and any
combination of GM6 and KM1-3 (Table 4). Conversely, in HIV-1
positive women, the combination of GM6(+/2) and KM1-3(+)
heterozygote was statistically significantly associated with in-
creased risk of PM (OR, 2.08; 95% CI, 1.12–3.89) while the
combination of GM6(+/2) and KM1-3(2) tended to be associated
with decreased risk of PM (OR, 0.47; 95% CI, 0.22–1.00)
(Table 4). Using the second combination (GM6 and KM3) in the
analysis of HIV-1 negative women (Table 5), the combination of
GM6(+) and KM3(+) homozygote was significantly associated with
decreased risk of PM (OR, 0.25; 95% CI, 0.08–0.80) (Table 5).
However, in HIV-1 positive women, the combination of GM6(+/
2) and KM3(2) was associated with increased risk of PM (OR,
2.1; 95% CI, 1.18–3.73) (Table 5). This result in HIV positive
women (Table 5) was partially in agreement with the finding in
Table 4, suggesting that combined GM6(+/2) with either KM1-3
or KM1 render women more susceptible to PM in HIV-1 positive
women. Analysis using the third combination of GM6 and KM1
genotypes showed no statistically significant association with PM
(data not shown). In addition, any combination of GM6 and KM
had no effect on other clinical outcomes such as placental malaria
parasite density, maternal anemia ,11 g/dl, low infant birth
weight or gestational age in HIV-1 negative women (data not
shown). In HIV-positive women, however, the combination of
GM6(+/2) and KM3(+) was associated with increased risk for
maternal anemia ,7 g/dl (OR, 5.25; 95% CI, 1.30–21.2;
P=0.021) (data not shown).
Hardy-Weinberg Equilibrium Tests
Malaria has a strong selective pressure on human genes [35,36].
In this study, we observed that the combination of GM6(+) and
KM3 homozygote was associated with decreased risk of PM in
HIV-negative women while the combined heterozygosity of
GM6(+/2) with either KM1-3 or KM1 was associated with
increased risk of PM in HIV-positive women. In order to examine
possible selection on GM6 and KM genes by diseases, departures
from HWE and F(is) were measured in the Kenyan adult study
population and further in the four disease groups (Tables 6 and 7).
Overall, HWE tests show that there was no deviation for KM
genotype frequency distribution in the whole study population
(P=0.75, F(is) =20.01, n = 728) (Table 7) while there was
significant deviation of GM6 genotype frequency distribution in
the study population with positive F(is) (P,0.001, F(is) = 0.26,
n = 725) (Table 6). When further stratified based on PM and HIV
status for the HWE test, the trend remains similar: there was no
deviation for KM genotype frequency distribution in the HIV-1
negative women regardless of PM status or in the HIV-1 positive
women without PM except a borderline significance of deviation
in HIV-1 positive women with PM showing negative F(is)
(P=0.05, F(is) =20.18). In contrast, there were still significant
deviations for GM6 genotype frequency distribution in the HIV-1
negative women with or without PM (P,0.001, F(is) = 0.30 and
F(is) = 0.34 respectively) and in the HIV-1 positive women without
PM (P,0.001, F(is) = 0.26), all of the three groups showing positive
F(is) (Table 6). But interestingly, there was no significant deviation
in HIV-1 positive women with PM for GM6 (P=0.61,
F(is) = 0.05).
Discussion
In this study, we report an association of GM6 and KM
genotypes on the risk of PM in HIV-1 infected and uninfected
pregnant women. Although none of the individual GM6 and KM
GM6 and KM Allotypes and Placental Malaria
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Table 1. Characteristics of HIV-1 negative and HIV-1 positive women, by placental malaria (PM) status.
Category/Characteristics HIV-1 negative women HIV-1 positive women
With PM (n=132) Without PM (n=107) Pa With PM (n=119) Without PM (n=370) Pa
Mother’s age, mean 6 SD, years 19.563.7 22.364.6 ,0.01 21.664.6 22.764.4 ,0.01
Gravidity
Primigravid 66.2 36.1 ,0.01 43.7 33.2 0.11
Secundigravid 18.8 29.6 …. 24.4 29.4 ….
Multigravid 15.0 34.3 …. 31.9 37.4 ….
Maternal peripheral malaria
Presence during third trimester 35.5 11.9 ,0.01 52.4 11.9 ,0.01
Presence at delivery 71.9 3.8 ,0.01 67.8 2.5 ,0.01
Malaria pigment present 88.0 1.9 ,0.01 88.2 0.5 ,0.01
Preterm delivery, ,37 weeks 7.5 6.5 0.81 10.1 9.4 0.85
Newborn birth weight, ,2500 g 6.8 0 ,0.01 13.5 5.9 0.01
Maternal anemia at delivery, g/dL
,7 7.0 3.8 0.39 13.4 6.3 0.03
,11 60.9 52.4 0.23 73.0 58.2 ,0.01
Anti-malarial use, third trimester 22.7 30.8 0.18 19.5 33.9 ,0.01
Place of living, semiurban (vs. urban) 33.8 23.6 0.09 31.4 25.7 0.24
Malaria transmission
season, third trimester
74.4 61.1 0.04 57.1 51.9 0.34
Maternal CD4 count, cells/ml
,350 …. …. 18.9 18.8 0.99
,500 …. …. 37.8 39.7 0.79
Median (interquartile range) …. …. 602 (422–841) 548 (376–798) 0.43
Maternal HIV-1 load, copies/ml
,1000 …. …. 41.2 49.3 0.05
1000–9999 …. …. 30.6 34.7 ….
$10, 000 …. …. 28.2 16.0 ….
Median (interquartile range) …. …. 1884 (200–14,703) 1021 (200–4,740) 0.07
Note: Data are percentage of women, unless otherwise noted. PM, Placental malaria; SD, Standard deviation.
aP values for univariable analysis are based on either the Pearson x2 test for comparison of proportions, or the Wilcoxon rank sum test for comparison of continuous
distributions.
doi:10.1371/journal.pone.0053948.t001
Table 2. Distribution of individual GM6 and KM genotypes in HIV-1 negative and HIV-1 positive women, by PM status.
Category HIV-1 negative women HIV-1 positive women
With PM (n=132) Without PM (n=107) With PM (n=119) Without PM (n=370) Pa Pb
GM6 genotype
GM6(+) 10.5 19.6 5.1 10.4 0.05 0.18
GM6(+/2) 24.8 29.9 31.4 26.7 …. ….
GM6(2) 64.7 50.5 63.5 62.9 …. ….
KM genotype
KM1 14.4 10.3 10.1 17.3 0.23 0.11
KM1-3 48.5 42.1 55.5 47.0 …. ….
KM3 37.1 47.6 34.4 35.7 …. ….
Note: Data are percentage of women. PM, Placental malaria.
aP value comparing PM+ and PM- in HIV-1 negative women.
bP value comparing PM+ and PM- in HIV-1 positive women.
doi:10.1371/journal.pone.0053948.t002
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genotypes were by themselves significantly associated with PM, the
combination of homozygous GM6(+) and KM3 was significantly
associated with decreased risk of PM infection in HIV negative
women. In HIV-1 positive women, the combination of heterozy-
gous GM6(+/2) with either KM1-3 or KM1 revealed an
increased risk of PM. These results suggest that GM6 and KM
genotypes, two unlinked genetic loci, could interact to influence
the susceptibility to PM infection in HIV-1 negative and positive
women by regulation of disease-specific humoral responses.
The combination of GM6(+) and KM3 homozygotes may
possibly affect susceptibility to PM infection in HIV-1 negative
women through immune regulation to influence the specificity,
subclass switch and titer of anti-malarial antibody responses. GM
markers are located on the constant region and there is evidence
for the involvement of these regions in antibody specificity with the
variable region, probably through the formation of idiotypic
determinants, modulation of antibody binding affinity and linkage
disequilibrium with the variable epitopes [28,37]. A previous study
conducted in non-pregnant Sudanese (all ages) showed that the
carriers of GM1,17 (present on IgG1); 5,13,14,6 (present on IgG3)
phenotype were associated with higher incidence of malaria and
higher baseline levels of total IgG and non-cytophilic IgG
subclasses than the non-carriers [38]. This same study further
suggested that the above-mentioned implication of GM 1,17;
5,13,14,6 phenotype might be mainly due to the GM6 allotype
involvement. Although there was an indication of limited
involvement of KM allotype in susceptibility to malaria infection
and antibody responses in this previous study [38], the current
study showed that the combination GM6(+) and KM3(+)
homozygote plays a role in the decreased risks of PM infection
in HIV negative women. This could be due to the difference in the
study models used, pregnant women vs. general population. In
addition, a more recent study in Beninese children showed an age-
related impact of GM 5,6,13,14;1,17 or KM1 phenotype on
malaria specific cytophilic IgG responses [39]. The interactive
effect of GM and KM phenotypes in the clearance and persistence
of hepatitis C infection has also been reported [19,20], suggesting
that Ig GM and KM allotypes are important immuno-genetic
factors in infectious diseases. Functionally, the c and k chains
carrying specific GM and KM allotypes by nonrandom pairing
could form a paratope with the necessary structure for recognition
[30] of the malaria antigen epitopes. Importantly, GM allotypes
may further interact with Fcc receptors (FccR) to affect disease risk
or protection. All GM epitopes including GM6, with the exception
of G1M3 and 17, are found on the Fc-portion of the IgG molecule
[20]. It is possible that particular FccR and GM6 alleles
epistatically interact [17] to influence the susceptibility to PM
infection. Our previous study showed that FccRIIa-H/H131
receptor for immunoglobulin G is associated with susceptibility to
PM [15]. An in vitro study conducted by others reported that
pregnancy-associated VSA-specific cytophilic IgGs promote
phagocytic clearance of parasite infected erythrocytes, suggesting
Table 3. Effect of individual GM6 and KM genotypes on the risk for PM in HIV-1 negative and positive women.
Genotypesa HIV-1 negative women HIV-1 positive women
PM (%)b Adjusted OR (95% CI) Pc PM (%)b Adjusted OR (95% CI) Pc
GM6(+) 40.0 0.47 (0.21 to 1.05) 0.065 13.6 0.47 (0.19 to 1.19) 0.11
GM6(+/2) 50.8 0.74 (0.39 to 1.41) 0.36 27.4 1.16 (0.73 to 1.86) 0.53
GM6(2) 61.4 1.00 …. 24.5 1.00 ….
KM1 63.3 1.48 (0.60 to 3.66) 0.39 10.1 0.62 (0.30 to 1.28) 0.19
KM1-3 58.7 1.52 (0.84 to 2.76) 0.16 27.5 1.25 (0.78 to 1.98) 0.35
KM3 49.0 1.00 …. 23.7 1.00 ….
Note: PM, Placental malaria; OR, odds ratios; CI, confidence interval.
aGM6(2) and KM3 are used as references respectively.
bFor HIV negative women, one missing GM6 typing data, n = 238; for HIV positive women, five missing GM6 or KM typing data, n = 484.
cP values are derived from multivariate logistic regression, controlling for gravidity, anti-malarial use during third trimester, and malaria transmission season.
doi:10.1371/journal.pone.0053948.t003
Table 4. Effect of combined GM6 and KM1-3 genotypes on the risk for PM in HIV-1 negative and positive women.
Genotypesa HIV-1 negative women HIV-1 positive women
PM (%) Adjusted OR (95% CI Pb PM (%) Adjusted OR (95% CI) Pb
GM6(+) KM1-3(+) 35.7 0.60 (0.18 to 2.05) 0.41 16.0 0.59 (0.19 to 1.87) 0.38
GM6(+) KM1-3(2) 42.9 0.62 (0.21 to 1.77) 0.37 10.5 0.29 (0.06 to 1.33) 0.11
GM6(+/2) KM1-3(+) 50.0 0.90 (0.36 to 2.28) 0.83 42.2 2.08 (1.12 to 3.89) 0.021
GM6(+/2) KM1-3(2) 52.9 1.04 (0.44 to 2.49) 0.93 14.3 0.47 (0.22 to 1.00) 0.051
GM6(2) KM1-3(+) 68.8 1.93 (0.92 to 4.07) 0.08 22.8 0.83 (0.47 to 1.41) 0.50
GM6(2) KM1-3(2) 54.7 1.00 …. 26.1 1.00 ….
Note: PM, Placental malaria; OR, odds ratios; CI, confidence interval.
aKM1-3(+) is KM1-3 heterozygote and KM1-3(2) includes KM1 and KM3 homozygotes. GM6(2)KM1-3(2) is used as reference.
bP values are derived from multivariable logistic regression, controlling for gravidity, anti-malarial use during third trimester, and malaria transmission season.
doi:10.1371/journal.pone.0053948.t004
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the contribution of this immune effector mechanism in the
decrease of parasite load in the placenta [40]. It is known that IgG
opsonized phagocytosis of P. falciparum infected erythrocytes could
be mediated by FccRI and FccRIIa [41]. In addition, the potential
effect of the cytophlic IgG3 involving Fcc receptors in protection
against P. falciparum malaria through phagocytosis of merozoites,
neutrophil respiratory bursts and monocyte-mediated growth
inhibition have been established in naturally acquired immunity
[42,43,44].
In HIV-1 positive women the combination of heterozygous
GM6(+/2) with either KM1-3 or KM1 was associated with
susceptibility to PM infection. This suggests that HIV-1 infection
could influence the relationship between GM and KM allotypes
and PM infection, possibly by altering malaria-specific antibody
responses. Indeed, several studies in pregnant women have
reported that HIV infection decreases frequency and concentra-
tion of malaria-specific antibodies and/or changes balance of IgG
subclasses against various antigens including pre-erythrocytic and
blood stage antigens as well as pregnancy-associated VSA with
impairment of opsonic phagocytic clearance of parasites
[13,14,40]. This could lead to the increased risk of PM infection
in HIV-1 positive women. In this study, we also observed that the
combination of heterozygous GM6(+/2) again with different KM,
homozygous KM3(+), was associated with maternal anemia
(Hb,7 g/dL) in HIV-1 positive women. Although the actual
mechanism by which the combination of GM6(+/2) and KM3
would regulate anemia in pregnant women is not clear, the result
indicates that GM6(+/2) could play a role in the risk of severe
maternal anemia, one symptom of malaria during pregnancy.
We also measured departure from HWE in GM6 and KM allele
frequencies and F(is) in the study population to evaluate possible
selection [33,45,46] by malaria on GM6 and KM as malaria has a
strong selection on human genes [35,36]. HWE tests clearly
showed that there was no deviation for KM genotype frequency
distribution in the study population. In contrast, an overall
significant deviation of GM6 genotype frequency distribution was
observed in the same population, showing significant positive F(is).
Positive F(is) indicates a deficit on heterozygotes in the population
[34]. Most importantly, when further stratified by PM and HIV
status there were still significant positive F(is) for GM6 in the HIV-
1 negative women regardless of PM and in the HIV-1 positive
women without PM while there was no significant deviation from
HWE in HIV-1 positive women with PM. Tests of departure from
HWE and F(is) have been used for different purposes; some have
used the tests for searching disease-susceptibility gene loci and
detecting selection, others have used them for genotyping quality
control [33,45,46,47]. However, HWE and F(is) results from our
study with distinct patterns between GM6 and KM and with
different strength among disease groups for GM6 were unlikely
due to genotype errors as we employed different quality control
measures for GM6 genotyping (see method section). In addition,
our study was not a typical case-control study; rather, a diseases-
stratified enrollment was used (see method section). Most likely,
GM6 showing overall significant positive F(is) indicates low
heterozygote fitness in the population possibly shaped by selection
Table 5. Effect of combined GM6 and KM3 genotypes on the risk for PM in HIV-1 negative and positive women.
Genotypesa HIV-1 negative women HIV-1 positive women
PM (%) Adjusted OR (95% CI) Pb PM (%) Adjusted OR (95% CI) Pb
GM6(+) KM3(+) 35.3 0.25 (0.08 to 0.80) 0.019 15.4 0.61 (0.13 to 2.89) 0.53
GM6(+) KM3(2) 44.4 0.48 (0.16 to 1.44) 0.19 12.9 0.56 (0.18 to 1.71) 0.31
GM6(+/2) KM3(+) 51.9 0.61 (0.24 to 1.57) 0.31 13.5 0.57 (0.24 to 1.36) 0.20
GM6(+/2) KM3(2) 51.4 0.53 (0.23 to 1.26) 0.15 36.6 2.10 (1.18 to 3.73) 0.011
GM6(2) KM3(+) 51.8 0.54 (0.26 to 1.15) 0.11 30.4 1.56 (0.91 to 2.71) 0.11
GM6(2) KM3(2) 67.5 1.00 …. 21.4 1.00 ….
Note: PM, Placental malaria; OR, odds ratios; CI, confidence interval.
aKM3(+) is KM3 homozygote while KM3(2) includes KM1 homozygote and KM1-3 heterozygote. GM6(2)KM3(2) is used as reference.
bP values are derived from multivariable logistic regression, controlling for gravidity, anti-malarial use during third trimester, and malaria transmission season.
doi:10.1371/journal.pone.0053948.t005
Table 6. Hardy-Weinberg Equilibrium Test for GM6 genotypes.





GM6 2 GM6+/2 GM6+ Total (n) GM6 2 GM6+ GM6 2 GM6+/2 GM6+ x2 P value F(is)
All women 446 200 79 725 0.75 0.25 411.2 269.6 44.2 48.3 ,0.001 0.26
HIV+/PM+ 75 37 6 118 0.79 0.21 74.1 38.8 5.1 0.3 0.61 0.05
HIV+/PM2 231 98 38 367 0.76 0.24 213.6 132.8 20.6 25.2 ,0.001 0.26
HIV2/PM+ 86 33 14 133 0.77 0.23 79.0 47.0 7.0 11.8 ,0.001 0.30
HIV2/PM2 54 32 21 107 0.65 0.35 45.8 48.4 12.8 12.3 ,0.001 0.34
Chi-square tests were used to determine deviation from HWE, and F(is) was calculated based on the formula F = 1– Het/HetHW, where Het is the number of
heterozygotes observed, and HetHW is the number of heterozygotes expected under HWE [33,34].
doi:10.1371/journal.pone.0053948.t006
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over time [33,34]. The results of no significant departure from
HWE in GM6 genotype frequency in HIV-1 positive women with
PM but strong positive F(is) in other three groups further suggest
that the group without low heterozygote fitness has less potential
for resistance to malaria and/or HIV-1 infection. This notion
could be partially explained by the results from our association
analysis above showing GM6(+) involvement in the association
with decreased risk of PM (homozygote advantage) while GM6(+/
2) was associated with increased risk of PM (heterozygote
disadvantage) regardless of HIV-1 status. As such, GM6 has
fitness value likely selected by malaria infection. The assertion that
GM6 is under selection by malaria is also supported by the fact
that the geographic distribution of GM6 related haplotypes
coincides with the region of high falciparum malaria and sickle-
cell allele prevalence [24].
Taken together, this study highlights the association between
GM6 and KM genotypes with PM in HIV-1 negative and HIV-1
positive women. These findings suggest that the combination of
homozygous GM6(+) and KM3 may protect against PM in HIV-1
negative women, while the HIV-1 positive women with hetero-
zygous GM6(+/2) combined with KM1-3 or KM1 may be more
susceptible to PM. In addition, the result of a deficit in
heterozygotes for GM6 in our study population (Kenyan pregnant
women) suggests that low GM6 heterozygous fitness could be due
to selection mainly by malaria infection. However, more studies in
other populations and in different malaria endemic areas are
needed to validate this finding.
Presentation of Results
This result was presented in part at the 59th Annual ASTMH
meeting, November 3–7, 2010, in Atlanta, Georgia, USA.
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